First trimester exposure to topiramate and the risk of oral clefts in the offspring: A systematic review and meta-analysis

Reproductive Toxicology
Abdulaziz M S AlsaadGideon Koren

Abstract

Topiramate (TPM) is an increasingly used drug during childbearing ages for treatment of epilepsy, migraine, and appetite suppression as well as for off-label indications such as sleep and psychiatric disorders. Presently, while some reports suggested an increased risk of oral cleft (OC), these reports are balanced by studies that could not confirm such association. We conducted a meta-analysis of all studies reporting on women exposed to TPM during pregnancy. Of the 2327 publications reviewed, 6 articles met the inclusion criteria including 3420 patients and 1,204,981 controls. The odd ratio (OR) of OC after the first trimester exposure to TPM exposure was 6.26 (95% confidence interval: 3.13-12.51; P = 0.00001). This study provides strong evidence that TPM is associated with an increased risk of OC in infants exposed to TPM during embryogenesis and should lead to a careful review of TPM use in women of reproductive ages.

References

Apr 12, 2001·The New England Journal of Medicine·L B HolmesL M Ryan
Oct 21, 2006·Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association·P Hauer
Nov 10, 2007·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Frank J E VajdaMervyn Eadie
Apr 22, 2008·Reproductive Toxicology·Asher OrnoyOrna Diav-Citrin
Jul 23, 2008·Neurology·S HuntUNKNOWN UK Epilepsy and Pregnancy Register
May 12, 2010·Headache·Tobias Kurth, Sonia Hernandez-Diaz
Sep 8, 2010·The Journal of Clinical Psychiatry·Heather A BerlinEric Hollander
Sep 8, 2010·Neurologic Clinics·Hrayr Attarian
May 19, 2011·JAMA : the Journal of the American Medical Association·Ditte Mølgaard-Nielsen, Anders Hviid
Oct 11, 2011·Annals of Epidemiology·Martha M WerlerUNKNOWN National Birth Defects Prevention Study
May 4, 2012·Neurology·S Hernández-DíazUNKNOWN North American AED Pregnancy Registry
May 12, 2012·Recent Patents on CNS Drug Discovery·Susan BarronJohn Littleton
Jun 26, 2012·Headache·Mark W GreenArun Bhattacharyya
Aug 25, 2012·American Journal of Obstetrics and Gynecology·Andrea V MargulisUNKNOWN National Birth Defects Prevention Study
Apr 3, 2014·Pharmacoepidemiology and Drug Safety·Daniel MinesK Arnold Chan

❮ Previous
Next ❯

Citations

Dec 22, 2015·Current Psychiatry Reports·Christina L Wichman
Sep 16, 2016·Der Nervenarzt·B Müffelmann, C G Bien
Oct 28, 2016·Seizure : the Journal of the British Epilepsy Association·Rebecca L Bromley, Gus A Baker
Aug 8, 2017·International Journal of Molecular Sciences·Yu-Heng LaiYau-Hung Chen
Nov 8, 2016·The Cochrane Database of Systematic Reviews·Jennifer WestonAnthony G Marson
Nov 23, 2018·BJOG : an International Journal of Obstetrics and Gynaecology·F C DenisonUNKNOWN Royal College of Obstetricians and Gynaecologists
Sep 3, 2020·Birth Defects Research·Stephen M KerrMartha M Werler
Mar 31, 2016·British Journal of Clinical Pharmacology·Joanne E GivenHelen Dolk
Oct 22, 2017·Clinical Chemistry·Kishore M GaddeHans-Rudolf Berthoud
Sep 25, 2020·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Chiara LupiSilvia Benemei
Dec 3, 2016·Headache·Stephen D Silberstein
May 25, 2016·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·W Timothy GarveyUNKNOWN Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines
Aug 21, 2021·Drug and Therapeutics Bulletin·Caroline Ovadia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Related Papers

Pharmacoepidemiology and Drug Safety
Daniel MinesK Arnold Chan
American Journal of Obstetrics and Gynecology
Andrea V MargulisNational Birth Defects Prevention Study
© 2021 Meta ULC. All rights reserved